Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Amphotericin B Lipid Complex Injection 100 mg
  Indications :
 

Empirical therapy for presumed fungal infections.

Treatment for confirmed fungal infections.

Treatment of patients with Aspergillus spp., Candida spp. and/or Cryptococcus spp. infections refractory to amphotericin B deoxycholate.

In patients where renal impairement or unacceptable toxicity precludes the use of amphotericin B deoxycholate.

Treatment of Visceral leishmaniasis.

   
  Dosage :
 

The recommended initial dose of Amphotin-Lip for each indication for adult and pediatric patients is as follows :

amphotin_lip_dosage_table_1

Doses recommended for visceral leishmaniasis are presented below:
amphotin_lip_dosage_table_2


Dosage Adjustment :

Renal Impairment : Not necessary with renal impairment if decreased renal function is due to amphotericin B the daily dose can be adjusted.

Hepatic Impairment : Administer with caution.
   
  Packing : 5 Single Dose Vials of 100 mg
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.